PfSPZ-LARC2

· Sanaria Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PfSPZ-LARC2, covering 2026-02-19 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human PfSPZ-LARC2 Vaccination/CHMI [Phase 1]